Network pharmacology combined with experiments to explore the molecular mechanism of Jiawei Erzhi pill protects against atherosclerosis by inhibiting ferroptosis.
JWEZP improved AS by inhibiting ferroptosis. The study provides a scientific basis for further research and validation of JWEZP as a potential therapeutic for AS.
Authors
- HE Shi-ping
- Junlong Luo (ORCID: https://orcid.org/0000-0003-3755-4616)
- Hong Chuangxiong
- Ran Chen (ORCID: https://orcid.org/0000-0002-2656-3907)
- Yiyi Zhang (ORCID: https://orcid.org/0000-0002-8663-5001)
- Le Sun (ORCID: https://orcid.org/0000-0002-5500-0329)
- M A Guiping
Institutions
- Beijing University of Chinese Medicine (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.06.012
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00